Cargando…
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AlphaMed Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947460/ https://www.ncbi.nlm.nih.gov/pubmed/29700211 http://dx.doi.org/10.1634/theoncologist.2018-0097 |